Skip to main content

DIADEMA PARTNERS LP

Position in APGE — Apogee Therapeutics, Inc.

CIK 2026172 MORRISTOWN, NJ

Position in APGE

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2024
6 quarters on record

Common Shares in APGE Over Time

Shares Held

Position Value (USD)

Derivatives in APGE

reported options exposure · as of Mar 31, 2026
CallValue
$18,727,825
CallShares
222,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DIADEMA PARTNERS LP holds $217,374,297 across 66 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in APGE

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $18,727,825 222,500
2025-12-31 $15,933,828 211,100
2025-09-30 $5,061,602 127,400
2025-09-30 $2,552,652 64,250
2025-06-30 $459,141 10,572
2025-06-30 $6,788,109 156,300
2025-03-31 $1,494,400 40,000
2025-03-31 $4,718,568 126,300
2024-12-31 $2,293,086 50,620